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Abstract 
The novel synthetic cationic peptide melimine is a chimera of two natural peptides, melittin and 
protamine. This peptide has a broad spectrum of antibacterial activity against both gram-
positive and gram-negative bacteria while having no toxicity in mammalian cells. Melimine 
was initially synthesised as a coating for contact lenses as a way of reducing keratitis, 
inflammation of the cornea. However, its antibacterial effects also have further potential use as 
an antimicrobial coating for other biomaterial surfaces. 
This peptide has been studied along with four peptide derivatives to determine the effects that 
peptide hydrophobicity, charge and size have on the peptides’ antibacterial properties through 
studying their peptide-membrane interactions. Melimine has previously been shown to reduce 
the integrity of membranes, observed through the leakage of dye from bacterial membranes. 
The membrane-peptide interactions were compared using advanced lipid membrane 
biophysical techniques, including in-silico structural modelling, fluorescent membrane dipole 
measures, differential scanning calorimetry, neutron reflectometry, dynamic light scattering 
and electrical impedance spectroscopy and Arrhenius measures of their interactions with 
tethered bilayer lipid membranes (tBLMs).  
Through analysing the results obtained from these biophysical techniques, the peptide-
membrane interactions of melimine and its derivatives were compared against known modes 
lipid membrane interactions of antimicrobial compounds. These interactions included the 
barrel-stave model, carpet model, interdigitated toroidal pore model, critical packing parameter 
model and other surfactant-like properties. The five peptides showed minimal peptide-
membrane interactions and an inability to span a lipid bilayer, leading to a postulation that 
these five peptides do not conform to having one of these aforementioned modes of action in 
killing bacteria. 
The limited peptide-membrane interactions of the five cationic peptides contrast with their 
known antibacterial activity against bacteria. This suggests that melimine and its derivatives 
may interact with other components of bacterial cell membranes; this could include 
extracellular components, such as porin channels. This research highlights that the assumption 
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activity requires reconsideration. This study emphasises the need for an alternative model of 
the antibacterial effects of cationic peptides such as melimine and its derivatives. 
 
 
 
 
 
 
 
 
 
 
 
  
